Report Detail
Global and United States Transdermal Drug Delivery Patches Market Report & Forecast 2022-2028
- RnM4419797 |
- 05 April, 2022 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Market Analysis and Insights: Global and United States Transdermal Drug Delivery Patches Market
This report focuses on global and United States Transdermal Drug Delivery Patches market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Transdermal Drug Delivery Patches market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Methyl Salicylate-based Patch accounting for % of the Transdermal Drug Delivery Patches global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Rx Channel was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Transdermal Drug Delivery Patches market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Transdermal Drug Delivery Patches Scope and Market Size
Transdermal Drug Delivery Patches market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Delivery Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Transdermal Drug Delivery Patches market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Transdermal Drug Delivery Patches market is segmented into
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application, the Transdermal Drug Delivery Patches market is segmented into
Rx Channel
OTC Channel
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Transdermal Drug Delivery Patches Market Share Analysis
Transdermal Drug Delivery Patches market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Drug Delivery Patches business, the date to enter into the Transdermal Drug Delivery Patches market, Transdermal Drug Delivery Patches product introduction, recent developments, etc.
The major vendors covered:
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Table of Contents
1 Study Coverage
- 1.1 Transdermal Drug Delivery Patches Product Introduction
- 1.2 Global Transdermal Drug Delivery Patches Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Transdermal Drug Delivery Patches Sales in US$ Million for the Year 2017-2028
- 1.2.2 Global Transdermal Drug Delivery Patches Sales in Volume for the Year 2017-2028
- 1.3 United States Transdermal Drug Delivery Patches Outlook 2017 VS 2022 VS 2028
- 1.3.1 United States Transdermal Drug Delivery Patches Sales in US$ Million for the Year 2017-2028
- 1.3.2 United States Transdermal Drug Delivery Patches Sales in Volume for the Year 2017-2028
- 1.4 Transdermal Drug Delivery Patches Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4.1 The Market Share of United States Transdermal Drug Delivery Patches in Global, 2017 VS 2022 VS 2028
- 1.4.2 The Growth Rate of Transdermal Drug Delivery Patches Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.5 Transdermal Drug Delivery Patches Market Dynamics
- 1.5.1 Transdermal Drug Delivery Patches Industry Trends
- 1.5.2 Transdermal Drug Delivery Patches Market Drivers
- 1.5.3 Transdermal Drug Delivery Patches Market Challenges
- 1.5.4 Transdermal Drug Delivery Patches Market Restraints
- 1.6 Study Objectives
- 1.7 Years Considered
2 Market by Type
- 2.1 Transdermal Drug Delivery Patches Market Segment by Type
- 2.1.1 Methyl Salicylate-based Patch
- 2.1.2 Rivastigmine Transdermal Patch
- 2.1.3 Fentanyl Transdermal Patch
- 2.1.4 Lidocaine Patch
- 2.1.5 Diclofenac Patch
- 2.1.6 Nicotine Transdermal Patch
- 2.1.7 Others
- 2.2 Global Transdermal Drug Delivery Patches Market Size by Type
- 2.2.1 Global Transdermal Drug Delivery Patches Sales in Value, by Type (2017, 2022 & 2028)
- 2.2.2 Global Transdermal Drug Delivery Patches Sales in Volume, by Type (2017, 2022 & 2028)
- 2.2.3 Global Transdermal Drug Delivery Patches Average Selling Price (ASP) by Type (2017, 2022 & 2028)
- 2.3 United States Transdermal Drug Delivery Patches Market Size by Type
- 2.3.1 United States Transdermal Drug Delivery Patches Sales in Value, by Type (2017, 2022 & 2028)
- 2.3.2 United States Transdermal Drug Delivery Patches Sales in Volume, by Type (2017, 2022 & 2028)
- 2.3.3 United States Transdermal Drug Delivery Patches Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
- 3.1 Transdermal Drug Delivery Patches Market Segment by Application
- 3.1.1 Rx Channel
- 3.1.2 OTC Channel
- 3.2 Global Transdermal Drug Delivery Patches Market Size by Application
- 3.2.1 Global Transdermal Drug Delivery Patches Sales in Value, by Application (2017, 2022 & 2028)
- 3.2.2 Global Transdermal Drug Delivery Patches Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 Global Transdermal Drug Delivery Patches Average Selling Price (ASP) by Application (2017, 2022 & 2028)
- 3.3 United States Transdermal Drug Delivery Patches Market Size by Application
- 3.3.1 United States Transdermal Drug Delivery Patches Sales in Value, by Application (2017, 2022 & 2028)
- 3.3.2 United States Transdermal Drug Delivery Patches Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 United States Transdermal Drug Delivery Patches Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Transdermal Drug Delivery Patches Competitor Landscape by Company
- 4.1 Global Transdermal Drug Delivery Patches Market Size by Company
- 4.1.1 Top Global Transdermal Drug Delivery Patches Manufacturers Ranked by Revenue (2021)
- 4.1.2 Global Transdermal Drug Delivery Patches Revenue by Manufacturer (2017-2022)
- 4.1.3 Global Transdermal Drug Delivery Patches Sales by Manufacturer (2017-2022)
- 4.1.4 Global Transdermal Drug Delivery Patches Price by Manufacturer (2017-2022)
- 4.2 Global Transdermal Drug Delivery Patches Concentration Ratio (CR)
- 4.2.1 Transdermal Drug Delivery Patches Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Transdermal Drug Delivery Patches in 2021
- 4.2.3 Global Transdermal Drug Delivery Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Transdermal Drug Delivery Patches Manufacturing Base Distribution, Product Type
- 4.3.1 Global Transdermal Drug Delivery Patches Manufacturers, Headquarters and Distribution of Producing Region
- 4.3.2 Manufacturers Transdermal Drug Delivery Patches Product Type
- 4.3.3 Date of International Manufacturers Enter into Transdermal Drug Delivery Patches Market
- 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4.5 United States Transdermal Drug Delivery Patches Market Size by Company
- 4.5.1 Top Transdermal Drug Delivery Patches Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Transdermal Drug Delivery Patches Revenue by Players (2020, 2021 & 2022)
- 4.5.3 United States Transdermal Drug Delivery Patches Sales by Players (2020, 2021 & 2022)
5 Global Transdermal Drug Delivery Patches Market Size by Region
- 5.1 Global Transdermal Drug Delivery Patches Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Transdermal Drug Delivery Patches Market Size in Volume by Region (2017-2028)
- 5.2.1 Global Transdermal Drug Delivery Patches Sales in Volume by Region: 2017-2022
- 5.2.2 Global Transdermal Drug Delivery Patches Sales in Volume Forecast by Region (2023-2028)
- 5.3 Global Transdermal Drug Delivery Patches Market Size in Value by Region (2017-2028)
- 5.3.1 Global Transdermal Drug Delivery Patches Sales in Value by Region: 2017-2022
- 5.3.2 Global Transdermal Drug Delivery Patches Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Transdermal Drug Delivery Patches Market Size YoY Growth 2017-2028
- 6.1.2 North America Transdermal Drug Delivery Patches Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Transdermal Drug Delivery Patches Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Transdermal Drug Delivery Patches Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Transdermal Drug Delivery Patches Market Size YoY Growth 2017-2028
- 6.3.2 Europe Transdermal Drug Delivery Patches Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Transdermal Drug Delivery Patches Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Transdermal Drug Delivery Patches Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Transdermal Drug Delivery Patches Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Transdermal Drug Delivery Patches Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Hisamitsu Pharmaceutical
- 7.1.1 Hisamitsu Pharmaceutical Corporation Information
- 7.1.2 Hisamitsu Pharmaceutical Description and Business Overview
- 7.1.3 Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.1.4 Hisamitsu Pharmaceutical Transdermal Drug Delivery Patches Products Offered
- 7.1.5 Hisamitsu Pharmaceutical Recent Development
- 7.2 Johnson & Johnson
- 7.2.1 Johnson & Johnson Corporation Information
- 7.2.2 Johnson & Johnson Description and Business Overview
- 7.2.3 Johnson & Johnson Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.2.4 Johnson & Johnson Transdermal Drug Delivery Patches Products Offered
- 7.2.5 Johnson & Johnson Recent Development
- 7.3 Novartis
- 7.3.1 Novartis Corporation Information
- 7.3.2 Novartis Description and Business Overview
- 7.3.3 Novartis Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.3.4 Novartis Transdermal Drug Delivery Patches Products Offered
- 7.3.5 Novartis Recent Development
- 7.4 UCB Pharma
- 7.4.1 UCB Pharma Corporation Information
- 7.4.2 UCB Pharma Description and Business Overview
- 7.4.3 UCB Pharma Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.4.4 UCB Pharma Transdermal Drug Delivery Patches Products Offered
- 7.4.5 UCB Pharma Recent Development
- 7.5 Mylan
- 7.5.1 Mylan Corporation Information
- 7.5.2 Mylan Description and Business Overview
- 7.5.3 Mylan Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.5.4 Mylan Transdermal Drug Delivery Patches Products Offered
- 7.5.5 Mylan Recent Development
- 7.6 Teva Pharmaceutical
- 7.6.1 Teva Pharmaceutical Corporation Information
- 7.6.2 Teva Pharmaceutical Description and Business Overview
- 7.6.3 Teva Pharmaceutical Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.6.4 Teva Pharmaceutical Transdermal Drug Delivery Patches Products Offered
- 7.6.5 Teva Pharmaceutical Recent Development
- 7.7 Nitto Denko
- 7.7.1 Nitto Denko Corporation Information
- 7.7.2 Nitto Denko Description and Business Overview
- 7.7.3 Nitto Denko Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.7.4 Nitto Denko Transdermal Drug Delivery Patches Products Offered
- 7.7.5 Nitto Denko Recent Development
- 7.8 Grünenthal
- 7.8.1 Grünenthal Corporation Information
- 7.8.2 Grünenthal Description and Business Overview
- 7.8.3 Grünenthal Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.8.4 Grünenthal Transdermal Drug Delivery Patches Products Offered
- 7.8.5 Grünenthal Recent Development
- 7.9 IBSA Group
- 7.9.1 IBSA Group Corporation Information
- 7.9.2 IBSA Group Description and Business Overview
- 7.9.3 IBSA Group Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.9.4 IBSA Group Transdermal Drug Delivery Patches Products Offered
- 7.9.5 IBSA Group Recent Development
- 7.10 GSK
- 7.10.1 GSK Corporation Information
- 7.10.2 GSK Description and Business Overview
- 7.10.3 GSK Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.10.4 GSK Transdermal Drug Delivery Patches Products Offered
- 7.10.5 GSK Recent Development
- 7.11 Luye Pharma Group
- 7.11.1 Luye Pharma Group Corporation Information
- 7.11.2 Luye Pharma Group Description and Business Overview
- 7.11.3 Luye Pharma Group Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.11.4 Luye Pharma Group Transdermal Drug Delivery Patches Products Offered
- 7.11.5 Luye Pharma Group Recent Development
- 7.12 Pfizer
- 7.12.1 Pfizer Corporation Information
- 7.12.2 Pfizer Description and Business Overview
- 7.12.3 Pfizer Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.12.4 Pfizer Products Offered
- 7.12.5 Pfizer Recent Development
- 7.13 Chattem
- 7.13.1 Chattem Corporation Information
- 7.13.2 Chattem Description and Business Overview
- 7.13.3 Chattem Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.13.4 Chattem Products Offered
- 7.13.5 Chattem Recent Development
- 7.14 Dr Reddy’s Laboratories
- 7.14.1 Dr Reddy’s Laboratories Corporation Information
- 7.14.2 Dr Reddy’s Laboratories Description and Business Overview
- 7.14.3 Dr Reddy’s Laboratories Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.14.4 Dr Reddy’s Laboratories Products Offered
- 7.14.5 Dr Reddy’s Laboratories Recent Development
- 7.15 Bayer
- 7.15.1 Bayer Corporation Information
- 7.15.2 Bayer Description and Business Overview
- 7.15.3 Bayer Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.15.4 Bayer Products Offered
- 7.15.5 Bayer Recent Development
- 7.16 Mundipharma
- 7.16.1 Mundipharma Corporation Information
- 7.16.2 Mundipharma Description and Business Overview
- 7.16.3 Mundipharma Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.16.4 Mundipharma Products Offered
- 7.16.5 Mundipharma Recent Development
- 7.17 Endo International
- 7.17.1 Endo International Corporation Information
- 7.17.2 Endo International Description and Business Overview
- 7.17.3 Endo International Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.17.4 Endo International Products Offered
- 7.17.5 Endo International Recent Development
- 7.18 Beijing Tide Pharmaceutical
- 7.18.1 Beijing Tide Pharmaceutical Corporation Information
- 7.18.2 Beijing Tide Pharmaceutical Description and Business Overview
- 7.18.3 Beijing Tide Pharmaceutical Transdermal Drug Delivery Patches Sales, Revenue and Gross Margin (2017-2022)
- 7.18.4 Beijing Tide Pharmaceutical Products Offered
- 7.18.5 Beijing Tide Pharmaceutical Recent Development
8 Industry Chain and Sales Channels Analysis
- 8.1 Transdermal Drug Delivery Patches Industry Chain Analysis
- 8.2 Transdermal Drug Delivery Patches Key Raw Materials
- 8.2.1 Key Raw Materials
- 8.2.2 Transdermal Drug Delivery Patches Distributors
- 8.3 Transdermal Drug Delivery Patches Production Mode & Process
- 8.4 Transdermal Drug Delivery Patches Sales and Marketing
- 8.4.1 Transdermal Drug Delivery Patches Sales Channels
- 8.4.2 Transdermal Drug Delivery Patches Distributors
- 8.5 Transdermal Drug Delivery Patches Customers
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.2 Data Source
- 10.2 Author Details
Summary:
Get latest Market Research Reports on Transdermal Drug Delivery Patches. Industry analysis & Market Report on Transdermal Drug Delivery Patches is a syndicated market report, published as Global and United States Transdermal Drug Delivery Patches Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Transdermal Drug Delivery Patches market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
